CMS lists Wegovy as an eligible GLP-1 drug for the Bridge when used to reduce excess body weight and maintain weight reduction
is yet another amino acid that focuses its energies on L-Lysine HCl bone strength, bone density, joint health, and collagen synthesis, helping the body recover in significantly less time
SHOW NOTES [ 00:00 ] Introduction [ 03:45 ] Kim's Childhood Weight Struggles [ 07:30 ] College trauma and major weight gain [ 11:15 ] Pregnancy, loss and plateau [ 15:00 ] Pandemic injury and a compassionate clinician [ 18:45 ] Starting GLP-1 therapy [ 22:15 ] Silencing the "Food Noise" [ 26:00 ] Understanding food noise vs
What If NNMT Inhibition Affects Methylation Pathways Over Time
Support Digestion
Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, et al